A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
de Leeuw ALMP, Giralt J, Tao Y, Benavente S, France Nguyen TV, Hoebers FJP, Hoeben A, Terhaard CHJ, Wai Lee L, Friesland S, Steenbakkers RJHM, Tans L, Heukelom J, Kayembe MT, van Kranen SR, Bartelink H, Rasch CRN, Sonke JJ, Hamming-Vrieze O.
de Leeuw ALMP, et al. Among authors: tans l.
Radiother Oncol. 2024 Apr 16;196:110281. doi: 10.1016/j.radonc.2024.110281. Online ahead of print.
Radiother Oncol. 2024.
PMID: 38636708